Portfolio (Quarterly)
Guide ↗
Tri Locum Partners LP
· CIK 0001826434| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JNJ | JOHNSON & JOHNSON | Healthcare | 414,503.0 | $101.3M | 14.22% | NEW | — | $244.44 | -6.3% |
| 2 | ISRG | INTUITIVE SURGICAL INC | Healthcare | 153,250.0 | $70.6M | 9.91% | NEW | — | $460.99 | -4.6% |
| 3 | TMO | THERMO FISHER SCIENTIFIC INC | Healthcare | 132,413.0 | $65.1M | 9.13% | NEW | — | $491.53 | -10.1% |
| 4 | — | ASCENDIS PHARMA A/S | — | 255,332.0 | $58.4M | 8.20% | NEW | — | $228.73 | — |
| 5 | VRTX | VERTEX PHARMACEUTICALS INC | Healthcare | 129,314.0 | $57.7M | 8.10% | NEW | — | $446.54 | -2.2% |
| 6 | LLY | ELI LILLY & CO | Healthcare | 61,795.0 | $56.8M | 7.98% | NEW | — | $919.77 | +7.4% |
| 7 | MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | 103,288.0 | $54.1M | 7.59% | NEW | — | $523.47 | -0.2% |
| 8 | DXCM | DEXCOM INC | Healthcare | 698,158.0 | $43.8M | 6.15% | NEW | — | $62.80 | +3.6% |
| 9 | UTHR | UNITED THERAPEUTICS CORP DEL | Healthcare | 70,370.0 | $41.7M | 5.86% | NEW | — | $592.98 | -4.4% |
| 10 | NUVL | NUVALENT INC | Healthcare | 308,506.0 | $31.6M | 4.44% | NEW | — | $102.45 | -2.5% |
| 11 | TEVA | TEVA PHARMACEUTICAL INDS LTD | Healthcare | 1,021,008.0 | $30.8M | 4.32% | NEW | — | $30.12 | +13.0% |
| 12 | JAZZ | JAZZ PHARMACEUTICALS PLC | Healthcare | 158,663.0 | $30.0M | 4.21% | NEW | — | $189.05 | +21.4% |
| 13 | ARGX | ARGENX SE | Healthcare | 31,635.0 | $23.1M | 3.24% | NEW | — | $730.25 | +9.2% |
| 14 | TARS | TARSUS PHARMACEUTICALS INC | Healthcare | 252,588.0 | $17.7M | 2.49% | NEW | — | $70.15 | -10.4% |
| 15 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 145,543.0 | $12.2M | 1.71% | NEW | — | $83.92 | -0.4% |
| 16 | AXSM | AXSOME THERAPEUTICS INC. | Healthcare | 62,116.0 | $10.5M | 1.47% | NEW | — | $169.02 | +34.1% |
| 17 | DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | 369,588.0 | $7.0M | 0.98% | NEW | — | $18.90 | +8.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%